Guidelines
HIV drug resistance
July 2017
Отчет оценочной
миссии
Январь 2014 г
The Open Infectious Diseases Journal, 2013, 7, (Suppl 1: M6) 54-59
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0169530 February 16, 2017
Hindamisaruanne
Juuni 2014
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Working Document - Updated -February 2009
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,... treatment and care
more
Technical Update
HIV Treatment
July 2017
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...ostics are highly accurate, cost-effective, reduce the time to treatment initiation, and impact patient-important outcomes.
more
DHS Working Papers No. 110 | Zimbabwe Working Papers No. 11